MyOme Strengthens Board with Appointment of Two Healthcare Leaders
MENLO PARK, Calif., April 21, 2026 /PRNewswire/ -- MyOme, a leading genomics innovation and risk modeling company, today announced the appointment of Sam Roosz and Dr. Ravi Thadhani to its Board of Directors. The two executives bring deep expertise spanning healthcare technology, data...
View original →